Safety of dexmedetomidine for the control of agitation in critically ill traumatic brain injury patients: a descriptive study
Véronique Bilodeau(Université de Montréal), David Williamson(Université de Montréal), Françis Bernard(Hôpital du Sacré-Cœur de Montréal), Lisa Burry(Mount Sinai Hospital), Martin Albert(Hôpital du Sacré-Cœur de Montréal), Mar Saavedra‐Mitjans(Hôpital du Sacré-Cœur de Montréal), Anne Julie Frenette(Université de Montréal)
Cited by 25
Related Papers
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
|Intensive Care Medicine|2021|5.1k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021
|Critical Care Medicine|2021|2.8k
Executive Summary: Surviving Sepsis Campaign: International Guidelines for the Management of Sepsis and Septic Shock 2021
|Critical Care Medicine|2021|495
Mortality associated with withdrawal of life-sustaining therapy for patients with severe traumatic brain injury: a Canadian multicentre cohort study
|Canadian Medical Association Journal|2011|488
Prevalence, Risk Factors, and Outcomes of Delirium in Mechanically Ventilated Adults*
|Critical Care Medicine|2014|341